The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Heparin Sodium Market Research Report 2025
Synopsis
The global Heparin Sodium market was valued at US$ 2935 million in 2023 and is anticipated to reach US$ 4320 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
Global Heparin Sodium key players include Shenzhen Hepalink, Bioiberica, Nanjing King-friend, Dongcheng Biochemicals and Changzhou Qianhong Bio-pharma. Global top five manufacturers hold a share about 54%. Europe is the largest market, with a share about 55%, followed by China and North America, with share 22% and 13%, separately. In term of application, the largest application is Low Molecular Weight Heparin Preparations, with a share of 93%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin Sodium.
The Heparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (Million Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Heparin Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Shenzhen Hepalink
Nanjing King-friend
Bioiberica
Dongcheng Biochemicals
Changzhou Qianhong Bio-pharma
Pfizer
Changshan Biochemical
Aspen Oss
Opocrin
Qingdao Jiulong Biopharmaceutical
Yino Pharma Limited
Dongying Tiandong Pharmaceutical
Xinbai Pharmaceuticals
Laboratorios Farmaceuticos ROVI
Sichuan Deebio
Segment by Type
Type A
Type B
Segment by Application
Standard Heparin Preparation
Low Molecular Weight Heparin Preparations
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Heparin Sodium market was valued at US$ 2935 million in 2023 and is anticipated to reach US$ 4320 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
Global Heparin Sodium key players include Shenzhen Hepalink, Bioiberica, Nanjing King-friend, Dongcheng Biochemicals and Changzhou Qianhong Bio-pharma. Global top five manufacturers hold a share about 54%. Europe is the largest market, with a share about 55%, followed by China and North America, with share 22% and 13%, separately. In term of application, the largest application is Low Molecular Weight Heparin Preparations, with a share of 93%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin Sodium.
The Heparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (Million Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Heparin Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Shenzhen Hepalink
Nanjing King-friend
Bioiberica
Dongcheng Biochemicals
Changzhou Qianhong Bio-pharma
Pfizer
Changshan Biochemical
Aspen Oss
Opocrin
Qingdao Jiulong Biopharmaceutical
Yino Pharma Limited
Dongying Tiandong Pharmaceutical
Xinbai Pharmaceuticals
Laboratorios Farmaceuticos ROVI
Sichuan Deebio
Segment by Type
Type A
Type B
Segment by Application
Standard Heparin Preparation
Low Molecular Weight Heparin Preparations
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Heparin Sodium Market Overview
1.1 Product Definition
1.2 Heparin Sodium by Type
1.2.1 Global Heparin Sodium Market Value Comparison by Type (2024-2030)
1.2.2 Type A
1.2.3 Type B
1.3 Heparin Sodium by Application
1.3.1 Global Heparin Sodium Market Value by Application (2024-2030)
1.3.2 Standard Heparin Preparation
1.3.3 Low Molecular Weight Heparin Preparations
1.4 Global Heparin Sodium Market Size Estimates and Forecasts
1.4.1 Global Heparin Sodium Revenue 2019-2030
1.4.2 Global Heparin Sodium Sales 2019-2030
1.4.3 Global Heparin Sodium Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Heparin Sodium Market Competition by Manufacturers
2.1 Global Heparin Sodium Sales Market Share by Manufacturers (2019-2024)
2.2 Global Heparin Sodium Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Heparin Sodium Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Heparin Sodium, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heparin Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heparin Sodium, Product Type & Application
2.7 Global Key Manufacturers of Heparin Sodium, Date of Enter into This Industry
2.8 Global Heparin Sodium Market Competitive Situation and Trends
2.8.1 Global Heparin Sodium Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Heparin Sodium Players Market Share by Revenue
2.8.3 Global Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Heparin Sodium Market Scenario by Region
3.1 Global Heparin Sodium Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Heparin Sodium Sales by Region: 2019-2030
3.2.1 Global Heparin Sodium Sales by Region: 2019-2024
3.2.2 Global Heparin Sodium Sales by Region: 2025-2030
3.3 Global Heparin Sodium Revenue by Region: 2019-2030
3.3.1 Global Heparin Sodium Revenue by Region: 2019-2024
3.3.2 Global Heparin Sodium Revenue by Region: 2025-2030
3.4 North America Heparin Sodium Market Facts & Figures by Country
3.4.1 North America Heparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Heparin Sodium Sales by Country (2019-2030)
3.4.3 North America Heparin Sodium Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Heparin Sodium Market Facts & Figures by Country
3.5.1 Europe Heparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Heparin Sodium Sales by Country (2019-2030)
3.5.3 Europe Heparin Sodium Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heparin Sodium Market Facts & Figures by Region
3.6.1 Asia Pacific Heparin Sodium Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Heparin Sodium Sales by Region (2019-2030)
3.6.3 Asia Pacific Heparin Sodium Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heparin Sodium Market Facts & Figures by Country
3.7.1 Latin America Heparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Heparin Sodium Sales by Country (2019-2030)
3.7.3 Latin America Heparin Sodium Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heparin Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Heparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Heparin Sodium Sales by Country (2019-2030)
3.8.3 Middle East and Africa Heparin Sodium Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Heparin Sodium Sales by Type (2019-2030)
4.1.1 Global Heparin Sodium Sales by Type (2019-2024)
4.1.2 Global Heparin Sodium Sales by Type (2025-2030)
4.1.3 Global Heparin Sodium Sales Market Share by Type (2019-2030)
4.2 Global Heparin Sodium Revenue by Type (2019-2030)
4.2.1 Global Heparin Sodium Revenue by Type (2019-2024)
4.2.2 Global Heparin Sodium Revenue by Type (2025-2030)
4.2.3 Global Heparin Sodium Revenue Market Share by Type (2019-2030)
4.3 Global Heparin Sodium Price by Type (2019-2030)
5 Segment by Application
5.1 Global Heparin Sodium Sales by Application (2019-2030)
5.1.1 Global Heparin Sodium Sales by Application (2019-2024)
5.1.2 Global Heparin Sodium Sales by Application (2025-2030)
5.1.3 Global Heparin Sodium Sales Market Share by Application (2019-2030)
5.2 Global Heparin Sodium Revenue by Application (2019-2030)
5.2.1 Global Heparin Sodium Revenue by Application (2019-2024)
5.2.2 Global Heparin Sodium Revenue by Application (2025-2030)
5.2.3 Global Heparin Sodium Revenue Market Share by Application (2019-2030)
5.3 Global Heparin Sodium Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shenzhen Hepalink
6.1.1 Shenzhen Hepalink Company Information
6.1.2 Shenzhen Hepalink Description and Business Overview
6.1.3 Shenzhen Hepalink Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shenzhen Hepalink Heparin Sodium Product Portfolio
6.1.5 Shenzhen Hepalink Recent Developments/Updates
6.2 Nanjing King-friend
6.2.1 Nanjing King-friend Company Information
6.2.2 Nanjing King-friend Description and Business Overview
6.2.3 Nanjing King-friend Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Nanjing King-friend Heparin Sodium Product Portfolio
6.2.5 Nanjing King-friend Recent Developments/Updates
6.3 Bioiberica
6.3.1 Bioiberica Company Information
6.3.2 Bioiberica Description and Business Overview
6.3.3 Bioiberica Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bioiberica Heparin Sodium Product Portfolio
6.3.5 Bioiberica Recent Developments/Updates
6.4 Dongcheng Biochemicals
6.4.1 Dongcheng Biochemicals Company Information
6.4.2 Dongcheng Biochemicals Description and Business Overview
6.4.3 Dongcheng Biochemicals Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dongcheng Biochemicals Heparin Sodium Product Portfolio
6.4.5 Dongcheng Biochemicals Recent Developments/Updates
6.5 Changzhou Qianhong Bio-pharma
6.5.1 Changzhou Qianhong Bio-pharma Company Information
6.5.2 Changzhou Qianhong Bio-pharma Description and Business Overview
6.5.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolio
6.5.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Heparin Sodium Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Changshan Biochemical
6.7.1 Changshan Biochemical Company Information
6.7.2 Changshan Biochemical Description and Business Overview
6.7.3 Changshan Biochemical Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Changshan Biochemical Heparin Sodium Product Portfolio
6.7.5 Changshan Biochemical Recent Developments/Updates
6.8 Aspen Oss
6.8.1 Aspen Oss Company Information
6.8.2 Aspen Oss Description and Business Overview
6.8.3 Aspen Oss Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aspen Oss Heparin Sodium Product Portfolio
6.8.5 Aspen Oss Recent Developments/Updates
6.9 Opocrin
6.9.1 Opocrin Company Information
6.9.2 Opocrin Description and Business Overview
6.9.3 Opocrin Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Opocrin Heparin Sodium Product Portfolio
6.9.5 Opocrin Recent Developments/Updates
6.10 Qingdao Jiulong Biopharmaceutical
6.10.1 Qingdao Jiulong Biopharmaceutical Company Information
6.10.2 Qingdao Jiulong Biopharmaceutical Description and Business Overview
6.10.3 Qingdao Jiulong Biopharmaceutical Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Qingdao Jiulong Biopharmaceutical Heparin Sodium Product Portfolio
6.10.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
6.11 Yino Pharma Limited
6.11.1 Yino Pharma Limited Company Information
6.11.2 Yino Pharma Limited Description and Business Overview
6.11.3 Yino Pharma Limited Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Yino Pharma Limited Heparin Sodium Product Portfolio
6.11.5 Yino Pharma Limited Recent Developments/Updates
6.12 Dongying Tiandong Pharmaceutical
6.12.1 Dongying Tiandong Pharmaceutical Company Information
6.12.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.12.3 Dongying Tiandong Pharmaceutical Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Dongying Tiandong Pharmaceutical Heparin Sodium Product Portfolio
6.12.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.13 Xinbai Pharmaceuticals
6.13.1 Xinbai Pharmaceuticals Company Information
6.13.2 Xinbai Pharmaceuticals Description and Business Overview
6.13.3 Xinbai Pharmaceuticals Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Xinbai Pharmaceuticals Heparin Sodium Product Portfolio
6.13.5 Xinbai Pharmaceuticals Recent Developments/Updates
6.14 Laboratorios Farmaceuticos ROVI
6.14.1 Laboratorios Farmaceuticos ROVI Company Information
6.14.2 Laboratorios Farmaceuticos ROVI Description and Business Overview
6.14.3 Laboratorios Farmaceuticos ROVI Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Laboratorios Farmaceuticos ROVI Heparin Sodium Product Portfolio
6.14.5 Laboratorios Farmaceuticos ROVI Recent Developments/Updates
6.15 Sichuan Deebio
6.15.1 Sichuan Deebio Company Information
6.15.2 Sichuan Deebio Description and Business Overview
6.15.3 Sichuan Deebio Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sichuan Deebio Heparin Sodium Product Portfolio
6.15.5 Sichuan Deebio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heparin Sodium Industry Chain Analysis
7.2 Heparin Sodium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heparin Sodium Production Mode & Process
7.4 Heparin Sodium Sales and Marketing
7.4.1 Heparin Sodium Sales Channels
7.4.2 Heparin Sodium Distributors
7.5 Heparin Sodium Customers
8 Heparin Sodium Market Dynamics
8.1 Heparin Sodium Industry Trends
8.2 Heparin Sodium Market Drivers
8.3 Heparin Sodium Market Challenges
8.4 Heparin Sodium Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Heparin Sodium Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Heparin Sodium Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Heparin Sodium Market Competitive Situation by Manufacturers in 2023
Table 4. Global Heparin Sodium Sales (Million Units) of Key Manufacturers (2019-2024)
Table 5. Global Heparin Sodium Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Heparin Sodium Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Heparin Sodium Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Heparin Sodium Average Price (USD/Million Units) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Heparin Sodium, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Heparin Sodium, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Heparin Sodium, Product Type & Application
Table 12. Global Key Manufacturers of Heparin Sodium, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Heparin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Sodium as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Heparin Sodium Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Heparin Sodium Sales by Region (2019-2024) & (Million Units)
Table 18. Global Heparin Sodium Sales Market Share by Region (2019-2024)
Table 19. Global Heparin Sodium Sales by Region (2025-2030) & (Million Units)
Table 20. Global Heparin Sodium Sales Market Share by Region (2025-2030)
Table 21. Global Heparin Sodium Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Heparin Sodium Revenue Market Share by Region (2019-2024)
Table 23. Global Heparin Sodium Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Heparin Sodium Revenue Market Share by Region (2025-2030)
Table 25. North America Heparin Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Heparin Sodium Sales by Country (2019-2024) & (Million Units)
Table 27. North America Heparin Sodium Sales by Country (2025-2030) & (Million Units)
Table 28. North America Heparin Sodium Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Heparin Sodium Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Heparin Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Heparin Sodium Sales by Country (2019-2024) & (Million Units)
Table 32. Europe Heparin Sodium Sales by Country (2025-2030) & (Million Units)
Table 33. Europe Heparin Sodium Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Heparin Sodium Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Heparin Sodium Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Heparin Sodium Sales by Region (2019-2024) & (Million Units)
Table 37. Asia Pacific Heparin Sodium Sales by Region (2025-2030) & (Million Units)
Table 38. Asia Pacific Heparin Sodium Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Heparin Sodium Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Heparin Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Heparin Sodium Sales by Country (2019-2024) & (Million Units)
Table 42. Latin America Heparin Sodium Sales by Country (2025-2030) & (Million Units)
Table 43. Latin America Heparin Sodium Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Heparin Sodium Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Heparin Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Heparin Sodium Sales by Country (2019-2024) & (Million Units)
Table 47. Middle East and Africa Heparin Sodium Sales by Country (2025-2030) & (Million Units)
Table 48. Middle East and Africa Heparin Sodium Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Heparin Sodium Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Heparin Sodium Sales (Million Units) by Type (2019-2024)
Table 51. Global Heparin Sodium Sales (Million Units) by Type (2025-2030)
Table 52. Global Heparin Sodium Sales Market Share by Type (2019-2024)
Table 53. Global Heparin Sodium Sales Market Share by Type (2025-2030)
Table 54. Global Heparin Sodium Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Heparin Sodium Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Heparin Sodium Revenue Market Share by Type (2019-2024)
Table 57. Global Heparin Sodium Revenue Market Share by Type (2025-2030)
Table 58. Global Heparin Sodium Price (USD/Million Units) by Type (2019-2024)
Table 59. Global Heparin Sodium Price (USD/Million Units) by Type (2025-2030)
Table 60. Global Heparin Sodium Sales (Million Units) by Application (2019-2024)
Table 61. Global Heparin Sodium Sales (Million Units) by Application (2025-2030)
Table 62. Global Heparin Sodium Sales Market Share by Application (2019-2024)
Table 63. Global Heparin Sodium Sales Market Share by Application (2025-2030)
Table 64. Global Heparin Sodium Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Heparin Sodium Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Heparin Sodium Revenue Market Share by Application (2019-2024)
Table 67. Global Heparin Sodium Revenue Market Share by Application (2025-2030)
Table 68. Global Heparin Sodium Price (USD/Million Units) by Application (2019-2024)
Table 69. Global Heparin Sodium Price (USD/Million Units) by Application (2025-2030)
Table 70. Shenzhen Hepalink Company Information
Table 71. Shenzhen Hepalink Description and Business Overview
Table 72. Shenzhen Hepalink Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 73. Shenzhen Hepalink Heparin Sodium Product
Table 74. Shenzhen Hepalink Recent Developments/Updates
Table 75. Nanjing King-friend Company Information
Table 76. Nanjing King-friend Description and Business Overview
Table 77. Nanjing King-friend Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 78. Nanjing King-friend Heparin Sodium Product
Table 79. Nanjing King-friend Recent Developments/Updates
Table 80. Bioiberica Company Information
Table 81. Bioiberica Description and Business Overview
Table 82. Bioiberica Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 83. Bioiberica Heparin Sodium Product
Table 84. Bioiberica Recent Developments/Updates
Table 85. Dongcheng Biochemicals Company Information
Table 86. Dongcheng Biochemicals Description and Business Overview
Table 87. Dongcheng Biochemicals Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 88. Dongcheng Biochemicals Heparin Sodium Product
Table 89. Dongcheng Biochemicals Recent Developments/Updates
Table 90. Changzhou Qianhong Bio-pharma Company Information
Table 91. Changzhou Qianhong Bio-pharma Description and Business Overview
Table 92. Changzhou Qianhong Bio-pharma Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 93. Changzhou Qianhong Bio-pharma Heparin Sodium Product
Table 94. Changzhou Qianhong Bio-pharma Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 98. Pfizer Heparin Sodium Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Changshan Biochemical Company Information
Table 101. Changshan Biochemical Description and Business Overview
Table 102. Changshan Biochemical Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 103. Changshan Biochemical Heparin Sodium Product
Table 104. Changshan Biochemical Recent Developments/Updates
Table 105. Aspen Oss Company Information
Table 106. Aspen Oss Description and Business Overview
Table 107. Aspen Oss Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 108. Aspen Oss Heparin Sodium Product
Table 109. Aspen Oss Recent Developments/Updates
Table 110. Opocrin Company Information
Table 111. Opocrin Description and Business Overview
Table 112. Opocrin Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 113. Opocrin Heparin Sodium Product
Table 114. Opocrin Recent Developments/Updates
Table 115. Qingdao Jiulong Biopharmaceutical Company Information
Table 116. Qingdao Jiulong Biopharmaceutical Description and Business Overview
Table 117. Qingdao Jiulong Biopharmaceutical Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 118. Qingdao Jiulong Biopharmaceutical Heparin Sodium Product
Table 119. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
Table 120. Yino Pharma Limited Company Information
Table 121. Yino Pharma Limited Description and Business Overview
Table 122. Yino Pharma Limited Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 123. Yino Pharma Limited Heparin Sodium Product
Table 124. Yino Pharma Limited Recent Developments/Updates
Table 125. Dongying Tiandong Pharmaceutical Company Information
Table 126. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 127. Dongying Tiandong Pharmaceutical Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 128. Dongying Tiandong Pharmaceutical Heparin Sodium Product
Table 129. Dongying Tiandong Pharmaceutical Recent Developments/Updates
Table 130. Xinbai Pharmaceuticals Company Information
Table 131. Xinbai Pharmaceuticals Description and Business Overview
Table 132. Xinbai Pharmaceuticals Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 133. Xinbai Pharmaceuticals Heparin Sodium Product
Table 134. Xinbai Pharmaceuticals Recent Developments/Updates
Table 135. Laboratorios Farmaceuticos ROVI Company Information
Table 136. Laboratorios Farmaceuticos ROVI Description and Business Overview
Table 137. Laboratorios Farmaceuticos ROVI Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 138. Laboratorios Farmaceuticos ROVI Heparin Sodium Product
Table 139. Laboratorios Farmaceuticos ROVI Recent Developments/Updates
Table 140. Sichuan Deebio Company Information
Table 141. Sichuan Deebio Description and Business Overview
Table 142. Sichuan Deebio Heparin Sodium Sales (Million Units), Revenue (US$ Million), Price (USD/Million Units) and Gross Margin (2019-2024)
Table 143. Sichuan Deebio Heparin Sodium Product
Table 144. Sichuan Deebio Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Heparin Sodium Distributors List
Table 148. Heparin Sodium Customers List
Table 149. Heparin Sodium Market Trends
Table 150. Heparin Sodium Market Drivers
Table 151. Heparin Sodium Market Challenges
Table 152. Heparin Sodium Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Heparin Sodium
Figure 2. Global Heparin Sodium Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Heparin Sodium Market Share by Type: 2023 & 2030
Figure 4. Type A Product Picture
Figure 5. Type B Product Picture
Figure 6. Global Heparin Sodium Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Heparin Sodium Market Share by Application: 2023 & 2030
Figure 8. Standard Heparin Preparation
Figure 9. Low Molecular Weight Heparin Preparations
Figure 10. Global Heparin Sodium Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Heparin Sodium Market Size (2019-2030) & (US$ Million)
Figure 12. Global Heparin Sodium Sales (2019-2030) & (Million Units)
Figure 13. Global Heparin Sodium Average Price (USD/Million Units) & (2019-2030)
Figure 14. Heparin Sodium Report Years Considered
Figure 15. Heparin Sodium Sales Share by Manufacturers in 2023
Figure 16. Global Heparin Sodium Revenue Share by Manufacturers in 2023
Figure 17. Global 5 and 10 Largest Heparin Sodium Players: Market Share by Revenue in Heparin Sodium in 2023
Figure 18. Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global Heparin Sodium Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Heparin Sodium Sales Market Share by Country (2019-2030)
Figure 21. North America Heparin Sodium Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Heparin Sodium Sales Market Share by Country (2019-2030)
Figure 25. Europe Heparin Sodium Revenue Market Share by Country (2019-2030)
Figure 26. Germany Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Heparin Sodium Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Heparin Sodium Revenue Market Share by Region (2019-2030)
Figure 33. China Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Heparin Sodium Sales Market Share by Country (2019-2030)
Figure 44. Mexico Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Heparin Sodium Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Heparin Sodium Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. U.A.E Heparin Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Heparin Sodium by Type (2019-2030)
Figure 53. Global Revenue Market Share of Heparin Sodium by Type (2019-2030)
Figure 54. Global Heparin Sodium Price (USD/Million Units) by Type (2019-2030)
Figure 55. Global Sales Market Share of Heparin Sodium by Application (2019-2030)
Figure 56. Global Revenue Market Share of Heparin Sodium by Application (2019-2030)
Figure 57. Global Heparin Sodium Price (USD/Million Units) by Application (2019-2030)
Figure 58. Heparin Sodium Value Chain
Figure 59. Heparin Sodium Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
